INT105253

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2002
Last Reported 2002
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 1
Disease Relevance 0
Pain Relevance 0.15

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Rnpep, F2rl1) peptidase activity (Rnpep) extracellular space (Rnpep)
aging (Rnpep) extracellular region (Rnpep) Golgi apparatus (Rnpep)
Rnpep (Rattus norvegicus)
F2rl1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
agonist 2 100.00 Very High Very High Very High
qutenza 2 63.20 Quite High

|}

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The PAR-2 agonist SLIGRL-NH2, administered intraperitoneally (i.p.) at 1-10 micromol/kg and 1.5-15 micromol/kg, in combination with amastatin, an aminopeptidase inhibitor, facilitated in vivo secretion of pancreatic and salivary amylase in a dose-dependent manner, respectively, in the mouse.
Positive_regulation (facilitated) of aminopeptidase Binding (combination) of PAR-2 associated with agonist
1) Confidence 0.02 Published 2002 Journal Life Sci. Section Abstract Doc Link 12231404 Disease Relevance 0 Pain Relevance 0.15

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox